APREA

aprea-logo

Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea Therapeutics was established in 2003 in Stockholms Lan, Sweden by Klas Wiman and Galina Selivanova.

#SimilarOrganizations #People #Financial #Website #More

APREA

Social Links:

Industry:
Biotechnology Health Care Medical Personal Health Pharmaceutical

Founded:
2003-01-01

Address:
Stockholm, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.aprea.com

Total Employee:
1+

Status:
Active

Contact:
+460850884504

Email Addresses:
[email protected]

Total Funding:
136.37 M USD

Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Content Delivery Network JsDelivr Nginx COVID-19 Gravity Forms Akamai Hosted Nginx 1.10 Formidable Pro Form


Similar Organizations

aeon-biopharma-logo

AEON Biopharma

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

astrazeneca-logo

AstraZeneca

AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.

cellectis-logo

Cellectis

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.

cstone-pharmaceuticals-logo

CStone Pharmaceuticals

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

medivir-logo

Medivir

Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases.

novartis-logo

Novartis

Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

sprout-pharmaceuticals-logo

Sprout Pharmaceuticals

Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.

Current Employees Featured

christian-schade_image

Christian Schade
Christian Schade President and chief executive officer @ Aprea
President and chief executive officer
2016-06-01

not_available_image

Lars Abrahmsen
Lars Abrahmsen Senior vice-president and chief scientific officer @ Aprea
Senior vice-president and chief scientific officer
2014-10-01

scott-coiante_image

Scott Coiante
Scott Coiante Senior Vice President & Chief Financial Officer @ Aprea
Senior Vice President & Chief Financial Officer
2019-08-01

gregory-korbel_image

Gregory Korbel
Gregory Korbel Senior Vice President & Chief Business Officer @ Aprea
Senior Vice President & Chief Business Officer
2021-03-01

richard-peters_image

Richard Peters
Richard Peters Director @ Aprea
Director
2020-06-01

Founder


galina-selivanova_image

Galina Selivanova

klas-wiman_image

Klas Wiman

Stock Details


Company's stock symbol is NASDAQ:APRE

Acquisitions List

Date Company Article Price
2022-05-16 Atrin Pharmaceuticals Atrin Pharmaceuticals acquired by Aprea N/A

Investors List

dafna-capital-management_image

Dafna Capital Management

Dafna Capital Management investment in Post-IPO Equity - Aprea

nantahala-capital-management_image

Nantahala Capital Management

Nantahala Capital Management investment in Post-IPO Equity - Aprea

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - Aprea

exome-asset-management_image

Exome Asset Management

Exome Asset Management investment in Post-IPO Equity - Aprea

stonepine-capital-management_image

Stonepine Capital Management

Stonepine Capital Management investment in Post-IPO Equity - Aprea

national-cancer-institute_image

National Cancer Institute

National Cancer Institute investment in Grant - Aprea

keiretsu-capital_image

Keiretsu Capital

Keiretsu Capital investment in Post-IPO Equity - Aprea

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series C - Aprea

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Aprea

karolinska_image

Karolinska

Karolinska investment in Series C - Aprea

Official Site Inspections

http://www.aprea.com Semrush global rank: 5.01 M Semrush visits lastest month: 1.65 K

  • Host name: 104.21.90.229
  • IP address: 104.21.90.229
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Aprea"

Home - Asia Pacific Real Assets Association

The Asia Pacific Real Assets Leadersโ€™ Congress is APREAโ€™s flagship event and the centerpiece of its 20th anniversary celebration.See details»

Aprea Therapeutics | Leaders in DDR-Targeted Solutions

Apreaโ€™s executive management team, Board of Directors and scientific founders are unified by their dedication to developing groundbreaking, precision therapeutics for patients with โ€ฆSee details»

Apria Home Medical Equipment and Support For Sleep Apnea, โ€ฆ

Apria is a leading US provider of home medical equipment delivery and clinical support, with services for COPD, sleep apnea, wound therapy, and more.See details»

Aprea - Crunchbase Company Profile & Funding

Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The โ€ฆSee details»

Aprea - Profiles & Contacts - Crunchbase

Aprea is a biopharmaceutical company that develops novel cancer therapeutics.See details»

What We Do - Aprea Therapeutics

And we continue to forge new paths. Today, Aprea Therapeutics is a clinical-stage biotechnology company focused on the development of novel, synthetic lethality-based therapies with direct โ€ฆSee details»

Aprea Therapeutics Board of Directors

Meet the Aprea Therapeutics board of directors. Their exceptional qualifications and expertise have fueled our growth as leaders in DDR-targeted therapeutics.See details»

Aprea - News & Analysis - Crunchbase

Mar 26, 2025 Aprea is a biopharmaceutical company that develops novel cancer therapeutics.See details»

Aprea Therapeutics Pipeline

The Aprea Therapeutics pipeline is focused on increasing the specificity and reducing the toxicity of DDR Inhibitors, giving patients more options.See details»

Lobbying Firm | Aprea & Company | California

Aprea & Company represents a wide variety of clients including Fortune 100 companies, national and statewide trade associations, public agencies, and nonprofits. We have had the privilege โ€ฆSee details»

APREA Team - Asia Pacific Real Assets Association

Sigrid is the Chief Executive Officer of Asia Pacific Real Assets Association (APREA). Based in Singapore, she is responsible for overseeing the strategic direction, initiatives and operations โ€ฆSee details»

Aprea Therapeutics - businessabc

4 days ago Aprea Therapeutics was founded in 2008 with a mission to develop anticancer compounds that specifically target tumor suppressing proteins. The company has since โ€ฆSee details»

APREA Members - Asia Pacific Real Assets Association

Real Assets TV Real Assets, Real People APREA Members Get in touch with APREA Learn more about the ins and outs of the Asia-Pacific real assets scene CONTACT US APREA strives to โ€ฆSee details»

Login - Apria

SIGN IN New to Apria PAP Portal? Register today Forgot Password? Send me a link to reset my password New to Apria? Please call us at 1-877-265-2426. For Kaiser Permanente members โ€ฆSee details»

Sexual Abuse Healing and Prevention Resources | Saprea

Saprea (formerly The Younique Foundation and Defend Innocence) is a nonprofit that provides resources to prevent and heal from sexual abuse.See details»

Aprea Therapeutics Launches New Corporate Website

BOSTON, April 06, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer โ€ฆSee details»

Membership - Asia Pacific Real Assets Association - aprea.asia

APREA strives to be the leading advocate for the real assets sector in Asia Pacific. Asia Pacific Real Assets Association Limited 18 Robinson Road #15-01, Singapore 048547 Tel: +65 6955 โ€ฆSee details»

Aprea Therapeutics Announces Strategic IP Portfolio Evolution in โ€ฆ

DOYLESTOWN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (โ€œApreaโ€, or the โ€œCompanyโ€), a clinical-stage biopharmaceutical company developing โ€ฆSee details»

Management Team - Aprea Therapeutics

Meet the Aprea Therapeutics management team of world-class precision oncology leaders who are developing groundbreaking DDR-targeted therapeutics.See details»

Aprea - Funding, Financials, Valuation & Investors - Crunchbase

Aprea has acquired Atrin Pharmaceuticals on May 16, 2022. Which types of acquisition does this organization make most frequently?See details»

linkstock.net © 2022. All rights reserved